Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Robson

Showing results (261-270 of 299) with videos related to

Pageof 30
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel AssociationsYing L Liu, Karen A Cadoo, Semanti Mukherjee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment SelectionWungki Park, Jiapeng Chen, Joanne F Chou, et al.
Nature|July 12, 2019
Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Journal of Medical Genetics|October 6, 2010
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancersK A Schrader, S Masciari, N Boyd, et al.
Nature|December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Journal of the National Cancer Institute|March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic NeoplasmsMaeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Therapeutic Implications of Germline Testing in Patients With Advanced CancersZsofia K Stadler, Anna Maio, Debyani Chakravarty, et al.
Nature Cancer|September 1, 2020
Alterations in <i>PTEN</i> and <i>ESR1</i> promote clinical resistance to alpelisib plus aromatase inhibitorsPedram Razavi, Maura N Dickler, Payal D Shah, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung CancerSemanti Mukherjee, Chaitanya Bandlamudi, Matthew D Hellmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based OutreachGoli Samimi, Marcus Q Bernardini, Lawrence C Brody, et al.
Pageof 30

Showing results (261-270 of 299) with videos related to

Sort By:
Pageof 30
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel AssociationsYing L Liu, Karen A Cadoo, Semanti Mukherjee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment SelectionWungki Park, Jiapeng Chen, Joanne F Chou, et al.
Nature|July 12, 2019
Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Journal of Medical Genetics|October 6, 2010
Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancersK A Schrader, S Masciari, N Boyd, et al.
Nature|December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Journal of the National Cancer Institute|March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic NeoplasmsMaeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Therapeutic Implications of Germline Testing in Patients With Advanced CancersZsofia K Stadler, Anna Maio, Debyani Chakravarty, et al.
Nature Cancer|September 1, 2020
Alterations in <i>PTEN</i> and <i>ESR1</i> promote clinical resistance to alpelisib plus aromatase inhibitorsPedram Razavi, Maura N Dickler, Payal D Shah, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung CancerSemanti Mukherjee, Chaitanya Bandlamudi, Matthew D Hellmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2017
Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based OutreachGoli Samimi, Marcus Q Bernardini, Lawrence C Brody, et al.
Pageof 30